Bronchiolitis is a common, self-limiting, seasonal viral respiratory tract infection in infancy
accounting for the majority of hospital admissions in this age group. Supportive care is the …

Background The treatment of infants with bronchiolitis is largely supportive. The role of
bronchodilators is controversial. Most studies of the use of bronchodilators have enrolled …

Bronchiolitis is a leading cause of acute illness and hospitalization for infants and young
children worldwide. It is usually a mild disease, but the few children developing severe …

Background Bronchiolitis is the most common lower respiratory tract infection in infants. Up
to 3% of all children in their first year of life are hospitalized with bronchiolitis …

Background There are no medications known that improve the outcome of infants with
bronchiolitis. Studies have shown the management of bronchiolitis to be varied. Objectives …

We enrolled 30 infants (median age 3 months, range 1–12 months), hospitalized for
bronchiolitis in a randomized double‐blind trial, to examine the efficacy and safety of …

Background Although numerous studies have explored the benefit of using nebulized
epinephrine or corticosteroids alone to treat infants with bronchiolitis, the effectiveness of …

Background Bronchiolitis describes a viral inflammation of the bronchioles in the lower
respiratory tract that is typically caused by infection with respiratory syncytial virus (RSV) …

OBJECTIVE: A network meta-analysis to compare the effectiveness of common treatments
for bronchiolitis in children aged≤ 2 years. DATA SOURCES: Medline, Embase, Cochrane …

Objective: In previously well infants hospitalized with acute viral bronchiolitis, the
effectiveness of repeated nebulized therapy with epinephrine (EPI) was compared with …